Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 9Active not recruiting 8Completed 6Suspended 2Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1CNS 1Breast 1

Conditions

Lung Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 117Carboplatin 47Nivolumab 46Paclitaxel 34Cyclophosphamide 34Cisplatin 33Gemcitabine 30atezolizumab 28Specimen Handling 26venetoclax 25Magnetic Resonance Spectroscopy 25Docetaxel 24fludarabine 23Pemetrexed 23Radiotherapy 22Biopsy 22Bevacizumab 22Ipilimumab 21Azacitidine 21Dexamethasone 19durvalumab 18Radiosurgery 18Fluorouracil 17Cetuximab 16Trastuzumab 15fludarabine phosphate 14Leucovorin 14Cytarabine 14tislelizumab 13Lenalidomide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mental Status and Dementia Tests × 1 year × Clear all
NCT06315296 2026-03-03

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Thomas Jefferson University

Phase NA Terminated
1 enrolled
BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡